16.16
-0.02 (-0.15%)
| Previous Close | 16.18 |
| Open | 16.19 |
| Volume | 1,958,542 |
| Avg. Volume (3M) | 4,442,240 |
| Market Cap | 4,800,731,136 |
| Price / Earnings (TTM) | 10.36 |
| Price / Earnings (Forward) | 23.31 |
| Price / Sales | 8.12 |
| Price / Book | 2.61 |
| 52 Weeks Range | |
| Earnings Date | 5 Nov 2025 |
| Profit Margin | 90.13% |
| Operating Margin (TTM) | 5.58% |
| Diluted EPS (TTM) | 1.70 |
| Quarterly Revenue Growth (YOY) | 23.50% |
| Quarterly Earnings Growth (YOY) | 243.00% |
| Total Debt/Equity (MRQ) | 6.09% |
| Current Ratio (MRQ) | 5.09 |
| Operating Cash Flow (TTM) | 88.78 M |
| Levered Free Cash Flow (TTM) | 133.39 M |
| Return on Assets (TTM) | 1.90% |
| Return on Equity (TTM) | 55.82% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Software - Application (US) | Mixed | Mixed |
| Software - Application (Global) | Mixed | Mixed | |
| Stock | Clearwater Analytics Holdings, | Bearish | Bearish |
AIStockmoo Score
| Analyst Consensus | 4.0 |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -2.5 |
| Average | 0.50 |
|
Clearwater Analytics describes its mission as aiming to be the world’s most trusted and comprehensive technology platform for the entire investment cycle. Clearwater has historically focused on back-office functions such as investment accounting, but with acquisitions such Enfusion, Beacon, and Bistro, the firm has broadened its focus with front-office and middle-office capabilities. Clearwater primarily serves insurance companies, asset managers, hedge funds, and corporate treasuries. Pro forma for Enfusion, about 76% of Clearwater’s revenue is generated in the US. |
|
| Sector | Technology |
| Industry | Software - Application |
| Investment Style | Small Growth |
| % Held by Insiders | 0.90% |
| % Held by Institutions | 89.04% |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 36.00 (RBC Capital, 122.84%) | Buy |
| Median | 30.00 (85.70%) | |
| Low | 26.00 (JP Morgan, 60.94%) | Buy |
| Average | 29.80 (84.46%) | |
| Total | 5 Buy | |
| Avg. Price @ Call | 16.84 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| JP Morgan | 06 Nov 2025 | 26.00 (60.94%) | Buy | 15.89 |
| UBS | 06 Nov 2025 | 30.00 (85.70%) | Buy | 15.89 |
| Wells Fargo | 06 Nov 2025 | 27.00 (67.13%) | Buy | 15.89 |
| DA Davidson | 04 Nov 2025 | 30.00 (85.70%) | Buy | 17.37 |
| 12 Aug 2025 | 34.00 (110.46%) | Buy | 18.95 | |
| RBC Capital | 17 Sep 2025 | 36.00 (122.84%) | Buy | 19.17 |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |